{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:21:45Z","timestamp":1788535305371,"version":"build-2803163510"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"abstract":"<jats:sec><jats:title>BACKGROUND AND OBJECTIVE:<\/jats:title><jats:p>Bilirubin\/albumin ratio (B\/A) may provide a better estimate of free bilirubin than total serum bilirubin (TSB), thus improving identification of newborns at risk for bilirubin encephalopathy. The objective of the study was to identify thresholds and compare specificities of TSB and B\/A in detecting patients with acute and posttreatment auditory and neurologic impairment.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>A total of 193 term\/near-term infants, admitted for severe jaundice to Cairo University Children\u2019s Hospital, were evaluated for neurologic status and auditory impairment (automated auditory brainstem response), both at admission and posttreatment by investigators blinded to laboratory results. The relationships of TSB and B\/A to advancing stages of neurotoxicity were compared by using receiver operating characteristic curves.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>TSB and B\/A ranged from 17 to 61 mg\/dL and 5.4 to 21.0 mg\/g, respectively; 58 (30%) of 193 subjects developed acute bilirubin encephalopathy, leading to kernicterus in 35 infants (13 lethal). Auditory impairment was identified in 86 (49%) of 173 infants at admission and in 22 of 128 at follow-up. In the absence of clinical risk factors, no residual neurologic or hearing impairment occurred unless TSB exceeded 31 mg\/dl. However, transient auditory impairment occurred at lower TSB and B\/A (22.9 mg\/dL and 5.7 mg\/g, respectively). Intervention values of TSB and B\/A set at high sensitivity to detect different stages of neurotoxicity had nearly the same specificity.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>Both TSB and B\/A are strong predictors of neurotoxicity, but B\/A does not improve prediction over TSB alone. Threshold values detecting all affected patients (100% sensitivity) increase with advancing severity of neurotoxicity.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2013-1764","type":"journal-article","created":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T05:09:45Z","timestamp":1413868185000},"page":"e1330-e1339","source":"Crossref","is-referenced-by-count":89,"title":["Serum Bilirubin and Bilirubin\/Albumin Ratio as Predictors of Bilirubin Encephalopathy"],"prefix":"10.1542","volume":"134","author":[{"given":"Iman","family":"Iskander","sequence":"first","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Gamaleldin","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"El Houchi","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"El Shenawy","sequence":"additional","affiliation":[{"name":"Audiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Seoud","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"El Gharbawi","sequence":"additional","affiliation":[{"name":"Clinical\/Chemical Pathology, Cairo University, Cairo, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem","family":"Abou-Youssef","sequence":"additional","affiliation":[{"name":"Clinical\/Chemical Pathology, Cairo University, Cairo, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Aravkin","sequence":"additional","affiliation":[{"name":"IBM Thomas J. Watson Research Center, Yorktown Heights, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Wennberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"issue":"1","key":"2021121015545492200_B1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"2021121015545492200_B2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1542\/peds.2005-0395","article-title":"Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns.","volume":"117","author":"Wennberg","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"2021121015545492200_B3","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1373\/clinchem.2008.121269","article-title":"Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice.","volume":"55","author":"Ahlfors","year":"2009","journal-title":"Clin Chem"},{"issue":"3","key":"2021121015545492200_B4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.93.3.488","article-title":"Criteria for exchange transfusion in jaundiced newborns.","volume":"93","author":"Ahlfors","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"2021121015545492200_B5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1442-200X.2011.03457.x","article-title":"Is bilirubin\/albumin ratio correlated with unbound bilirubin concentration?","volume":"54","author":"Sato","year":"2012","journal-title":"Pediatr Int"},{"issue":"1","key":"2021121015545492200_B6","first-page":"28","article-title":"Bilirubin\/albumin ratio for predicting acute bilirubin-induced neurologic dysfunction.","volume":"21","author":"Ardakani","year":"2011","journal-title":"Iran J Pediatr"},{"issue":"6","key":"2021121015545492200_B7","doi-asserted-by":"crossref","first-page":"e99466","DOI":"10.1371\/journal.pone.0099466","article-title":"The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial\u2014BARTrial.","volume":"9","author":"Hulzebos","year":"2014","journal-title":"PLoS ONE"},{"key":"2021121015545492200_B8","first-page":"746","article-title":"BIND\u2014A clinical score for bilirubin induced neurologic dysfunction in newborns.","volume":"104","author":"Johnson","year":"1999","journal-title":"Pediatrics"},{"issue":"432","key":"2021121015545492200_B9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.1999.tb01165.x","article-title":"Automated auditory brainstem response in neonatal hearing screening.","volume":"88","author":"van Straaten","year":"1999","journal-title":"Acta Paediatr Suppl"},{"issue":"1","key":"2021121015545492200_B10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.jp.7211157","article-title":"Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND).","volume":"25","author":"Shapiro","year":"2005","journal-title":"J Perinatol"},{"issue":"3","key":"2021121015545492200_B11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3476(05)82056-6","article-title":"New Ballard Score, expanded to include extremely premature infants.","volume":"119","author":"Ballard","year":"1991","journal-title":"J Pediatr"},{"issue":"6","key":"2021121015545492200_B12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/clinchem\/33.6.769","article-title":"Delta bilirubin: absorption spectra, molar absorptivity, and reactivity in the diazo reaction.","volume":"33","author":"Doumas","year":"1987","journal-title":"Clin Chem"},{"key":"2021121015545492200_B13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0026-265X(70)90093-7","article-title":"Ultramicroestimation of human serum albumin: binding cationic dye 5,5\u2032dibromo-o cresolsulfonphthalein.","volume":"15","author":"Carter","year":"1970","journal-title":"Microchem J"},{"key":"2021121015545492200_B14","first-page":"490","article-title":"Bilirubin and brain injury","volume-title":"Neurology of the Newborn","author":"Volpe","year":"2001","edition":"3rd ed."},{"key":"2021121015545492200_B15","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/jp.2008.211","article-title":"Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).","volume":"29","author":"Johnson","year":"2009","journal-title":"J Perinatol"},{"issue":"3","key":"2021121015545492200_B16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/j.semperi.2011.02.003","article-title":"The clinical syndrome of bilirubin-induced neurologic dysfunction.","volume":"35","author":"Johnson","year":"2011","journal-title":"Semin Perinatol"},{"issue":"1","key":"2021121015545492200_B17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/14992020903160892","article-title":"Multi-site diagnosis and management of 260 patients with auditory neuropathy\/dys-synchrony (auditory neuropathy spectrum disorder).","volume":"49","author":"Berlin","year":"2010","journal-title":"Int J Audiol"},{"issue":"11","key":"2021121015545492200_B18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.ijporl.2010.08.007","article-title":"Auditory neuropathy spectrum disorder in late preterm and term infants with severe jaundice.","volume":"74","author":"Saluja","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"2021121015545492200_B19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.semperi.2011.02.011","article-title":"Auditory impairment in infants at risk for bilirubin-induced neurologic dysfunction.","volume":"35","author":"Shapiro","year":"2011","journal-title":"Semin Perinatol"},{"issue":"1","key":"2021121015545492200_B20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2249-4847.109243","article-title":"Performance evaluation of hematologic scoring system in early diagnosis of neonatal sepsis.","volume":"2","author":"Makkar","year":"2013","journal-title":"J Clin Neonatol"},{"issue":"4","key":"2021121015545492200_B21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1542\/peds.62.4.460","article-title":"Absence of kernicterus in low-birth weight infants from 1971 through 1976: comparison with findings in 1966 and 1967.","volume":"62","author":"Pearlman","year":"1978","journal-title":"Pediatrics"},{"issue":"15","key":"2021121015545492200_B22","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/sim.1438","article-title":"Analysis of clustered matched-pair data.","volume":"22","author":"Durkalski","year":"2003","journal-title":"Stat Med"},{"key":"2021121015545492200_B23","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","volume-title":"The Statistical Evaluation of Medical Tests for Classification and Prediction","author":"Pepe","year":"2003"},{"issue":"8","key":"2021121015545492200_B24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.26719\/2012.18.8.882","article-title":"Root causes for late presentation of severe neonatal hyperbilirubinaemia in Egypt.","volume":"18","author":"Iskander","year":"2012","journal-title":"East Mediterr Health J"},{"key":"2021121015545492200_B25"},{"issue":"4","key":"2021121015545492200_B26","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-0206","article-title":"Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia.","volume":"128","author":"Gamaleldin","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"2021121015545492200_B27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004310051029","article-title":"Neurodevelopmental outcome at 1 year in Zimbabwean neonates with extreme hyperbilirubinaemia.","volume":"158","author":"Wolf","year":"1999","journal-title":"Eur J Pediatr"},{"issue":"5","key":"2021121015545492200_B28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0031-1274506","article-title":"Risk assessment for adverse outcome in term and late preterm neonates with bilirubin values of 20 mg\/dL or more.","volume":"28","author":"Weng","year":"2011","journal-title":"Am J Perinatol"},{"issue":"6 pt 1","key":"2021121015545492200_B29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1542\/peds.111.6.1303","article-title":"Infants with bilirubin levels of 30 mg\/dL or more in a large managed care organization.","volume":"111","author":"Newman","year":"2003","journal-title":"Pediatrics"},{"issue":"18","key":"2021121015545492200_B30","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa054244","article-title":"Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.","volume":"354","author":"Newman","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"2021121015545492200_B31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000343261","article-title":"Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.","volume":"103","author":"Smits-Wintjens","year":"2013","journal-title":"Neonatology"},{"issue":"5","key":"2021121015545492200_B32","doi-asserted-by":"crossref","first-page":"F384","DOI":"10.1136\/adc.2007.134056","article-title":"Usefulness of the bilirubin\/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants.","volume":"93","author":"Hulzebos","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"2021121015545492200_B33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1542\/peds.69.4.481","article-title":"Unbound bilirubin and kernicterus in low-birth-weight infants.","volume":"69","author":"Cashore","year":"1982","journal-title":"Pediatrics"},{"issue":"6","key":"2021121015545492200_B34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1442-200X.1992.tb01024.x","article-title":"Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants.","volume":"34","author":"Nakamura","year":"1992","journal-title":"Acta Paediatr Jpn"},{"issue":"2","key":"2021121015545492200_B35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0014-5793(69)80307-8","article-title":"Binding of bilirubin to human serum albumin - determination of the dissociation constants.","volume":"5","author":"Jacobsen","year":"1969","journal-title":"FEBS Lett"},{"issue":"2","key":"2021121015545492200_B36","doi-asserted-by":"crossref","first-page":"G356","DOI":"10.1152\/ajpgi.2000.279.2.G356","article-title":"Role of apolipoprotein D in the transport of bilirubin in plasma.","volume":"279","author":"Goessling","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"18","key":"2021121015545492200_B37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJM195210302471802","article-title":"Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus.","volume":"247","author":"Hsia","year":"1952","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121015545492200_B38","doi-asserted-by":"crossref","DOI":"10.1542\/peds.114.1.e130","article-title":"An evidence-based review of important issues concerning neonatal hyperbilirubinemia.","volume":"114","author":"Ip","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"2021121015545492200_B39","first-page":"304","article-title":"Bilirubin beyond the blood-brain barrier.","volume":"81","author":"Perlman","year":"1988","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/5\/e1330\/912626\/peds_2013-1764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/5\/e1330\/912626\/peds_2013-1764.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T04:26:32Z","timestamp":1717475192000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/5\/e1330\/75894\/Serum-Bilirubin-and-Bilirubin-Albumin-Ratio-as"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,11,1]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2013-1764","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,1]]}}}